Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
They need to get pink if they plan to add any SH value. CE screws us all.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
It would be nice to see them trade under the omhe symbol to recover some of the money we've all lost.
I'd like them to change the name. I sent them an email some time ago with a giant list of everything that was simular and pleaded with them to be more u-neak. I want to believe they got the memo but we won't know until they're ready to publicly state the status of everything they've been doing.
Do you think with all that you found it will still trade under omhe symbol?
COMMERCIALIZATION WILL BEGIN IN Q3 2023.
Our pipeline is positioned to deliver both near-term and sustained growth in two waves:? In the near-term, the OTC formulation launch through FY2023 will start bringing a steady revenue stream, representing best-in-class or first-in-class therapies. Looking to FY2024 and beyond, our R&D engine with internal research capabilities and external partnerships is expected to deliver a steady stream of next-generation pain therapies that will sustain our growth.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
I think they need to improve some aggressive marketing and this will go well!
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
Other movement as well on other fronts I picked up on recently to.
Looks like a huge buy on omhe today . 400k shares worth
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
update now to 3 weeks out
This Cause is hereby reset for Jury/Non-Jury trial before the undersigned Judge in
the Dade County Courthouse, 73 West Flagler Street, Miami, Florida 33130, for the 3
week period commencing 05/08/2023 or as soon thereafter as the same may be
heard.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
lmao. ive launched my own company recently tired of waiting for rags to riches off the backs of others. some backs are crooked my friend.
im not ready to write this one off yet some signs of a pulse exist relivra.com example and we are 7 years into this so i guess why not eh... cant take an L if you dont give up
waiting to see what happens after andrey gets nailed to the cross for 500k and can rise against all odds or if its all just dead. everyone loves a good come back story omnihealth parks n rec
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
LMAO - So you're still stuck here.
Hey Matt, got any plans to take a bike ride to meet up with Les over at BULT HQ and then ride your bike over to Bot HQ in Puerto Rico?
OMG, you're still stuck in this looser! BULT welcomes you to the squeal or OMHE. LMAO
OMG, you're still here!
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
Matt, thanks for the updates.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
Ty for keeping omhe shareholders updated.
should get a court update in 12 days or so.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
Andrey keeps trying to kick the can.
*****ENOUGH SAID !!! OMHE HAS A SKULL&CROSSBONES LABEL ON OTC MARKETS, NO CURRENT BUSINESS VENTURES
https://www.otcmarkets.com/stock/OMHE/overview
ZERO PROOF FROM THE COMPANY OF ANY CURRENT BUSINESS VENTURES
COMPANY HAS NO BUSINESS LICENCE
ZERO SOURCE OF REVENUE !!!
COMPANY DOES NOT RESPOND TO EMAILS OR ANSWER THE PHONE ??? - SO MUCH FOR THAT BS FALSE JARGON MALECON PHARMCY HAS NOT BEEN SOLD
GLAD I DONT OWN OMHE SHELL JUNK SHARES !
Matt, thanks for that great information!
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
Court case moved to trial by Judge. Should be over sooner than planned. Was July. Now well find out months sooner.
All that matters is what's happening now and things are quite looking good here for the future. I guess there is plenty of money to be made here and hoping it will happen on several occasions. The party and the big run hasn't even started.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
subsidiaries/holding companies
------------------------------------------------------------------------
Nexa Biosciences LLC, Entourage Biotech LLC, Age Lock biotech LLC, malecon pharmacy, LLC
celebrity brands, llc , miami executive pharmacy , lx retail group
focused on the following areas
healthcare, pharma, wellness, regenerative medicine, anti-aging, skin care, cannabis, and biotech
Interesting. Could you please identify the subsidiaries? Thanks!
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
We now have our 6 subsidiaries uncovered.
NEXA BIOSCIENCES, LLC. notice ADF signature on the TEAS at bottom.
relivra.com
an omnihealth, inc subisidairy.
board intro updated to reflect this new development.
Will do I have info I've needed to put in the intro for awhile. Stay tuned
Matt, could you please explain this? Thanks!
Quote below from replied-to post:
COMMERCIALIZATION WILL BEGIN IN Q3 2023. Post trial.
*****CEO stole shareholders money and pocketed the money from selling Malecon Pharmacy
ENOUGH SAID
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
We fly or die July/23. Post court case That's gunna be crazy. Can't wait.
Definitely the stock to accumulate now as more and more are recognizing the value.
*****ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET
ENOUGH SAID
Followers
|
172
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
37542
|
Created
|
01/05/15
|
Type
|
Free
|
Moderators 1vman mattsinvestmentclub |
CAVEAT EMPTOR HERE !!!
https://www.otcmarkets.com/stock/OMHE/overview
OMHE NO LONGER HAS A BUSINESS_LICENCE???_NVSOS_FILINGS
1/31/19
https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=4vj3QOGJMl1j1dl5DXIppQ%253d%253d&nt7=0
BUYER BEWARE !!!
MALECON
PHARMACIES ASSETS HAVE BEEN
SOLD TO WALGREENS !!!
OMHE ONLY SOURCE OF REVENUE IS NOW GONE !!!
MALECON PHARMACY LICENCE EXPIRED FEB 28TH , STILL NO
WORKING PHONE NUMBER THAT CONNECTS TO PHARMACY !!!!
https://appsmqa.doh.state.fl.us/MQASearchServices/HealthcareProviders/LicenseVerification?LicInd=614&Procde=2205&org=MALECON%20PHARMACY%20INC%20
CURRENT PICTURE BELOW OF MALECON PHARMACY CLOSE UP
CONCERENED SHAREHOLDERS NEED TO MAKE 2 SIMPLE CALLS!!!
TO VERIFY - FIRST CALL MALECOM - NOW WALGREENS
5066 W 16TH AVE , HIALEAH , FL 33012
305-558-8551
SECONDLY CALL WALGREENS IR FIRM !!!
Gerald Gradwell
Ashish Kohli, CFA
Deborah Walter
Email Address: investor.relations@wba.com
Phone +1 (847) 315-2922
FACTS ARE !PHONE CALLS ARE AN IMPORTANT_PART_OF_ANY_SERIOUS_INVESTORS DD
THAT BEING SAID THE DD ON THE SALE OF OMHES MALECON IS SOLID AND 100%
VERIFIABLE FOR THOSE SHAREHOLDERS INTERESTED IN PROTECTING THEIR INVESTMENT
WITH A FEW SIMPLE PHONE CALLS
NONE OF THE NUMBERS BELOW CONNECT TO MALECON PHARMACY - HUGE RED FLAG
STOCK IS CURRENTLY BEING DILUTED - HERES WHAT TO WATCH FOR
http://chedstrading.blogspot.com/2015/11/market-makers-who-are-they-and-how-are.html
HAS CEO ANDREY FLED WITH SHAREHOLDERS MONEY ???
https://www.pr.com/press-release/795505
Omni Health : Announces CEO Resignation
Miami, FL, September 27, 2019 --(PR.com)-- Omni Health, Inc., (OTC: OMHE) Andrey Soloviev announces his resignation from the position of CEO of Omni Health, Inc. effective 08/20/2019.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual
future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based
on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations
and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution
plans and strategies.
Contact Information:
Omni Health
Andrey Soloviev
305-558-8551
Contact via Email
Read the full story here: https://www.pr.com/press-release/795505
https://m.marketscreener.com/OMNI-HEALTH-INC-55018345/news/Omni-Health-Announces-CEO-Resignation-29269066/
FURTHER PROOF MALECON PHARMACY IS CLOSED
FOR GOOD
In reply to: | Date:9/17/2019 10:30:22 AM Post #31609 of 32599 |
we have definite proof that malecon has been closed. fedex miami reached out to me to confirm this. all packages have successfully been delivered. malecon is not deliverable because the location is closed as planned by the management team |
BEWARE OF FALSE INFORMATION REGARDING THIS
FORM BELOW -- IT IS NOT TO REINSTATE MALECON
PHARMACIES BUSINESS LICENCE
this form is to change the registered office and/or
registered agent it is not an application to reinstate
Malecon Pharmacy
The registered agent is the person who is appointed as
the contact to receive important documents on behalf
of the company, such as service of process for
lawsuits. They also ensure
compliance with annual report filing deadlines and
receive other important notices for the company.
Why is Andrey using the address of a boarded up
building in a strip mall below ( where the old malecon
pharmacy was !!! ) ???
HERES WHY !!! BCUZ HES STILL PAYING THE LEASE ON THAT
SPACE FOR OVER $8000.00/MONTH
Source
https://backend.otcmarkets.com/otcapi/company/financial-report/199080/content
DELISTING COMING HERE SOON
A NEW PROPOSED SEC RULE OMHE does not have any current info/disclosures posted on OTC
markets
SEC filed a proposal that will become effective after the 60 day period and time for comments expires.
Essentially the proposed RULE will remove all 15c2-11 qualifications for Market Maker representation
when there is NO CURRENT information/disclosures from every OTC stock. This RULE will adversely
affect every delinquent SEC registered stock and every not-registered stock on the OTC that has no
current info/disclosures.
This RULE will diminish the need for SEC Suspensions where the SEC has to spend time to find
delinquent SEC Registered stocks and OTC stocks that DO NOT have any current information.
The new RULE will place all responsibility on Brokers and Market Makers to ensure ALL information
and disclosures are current, and if not current to remove their quotation services, automatically placing
those stocks on the Grey Market by default.
OMHE can go to the Grey Market by default as well as 100's of other no-disclosure stocks that will lose
their Market Maker representation.
https://www.sec.gov/rules/proposed/2019/34-87115.pdf
BETWEEN THE ASTERISKS IS MAINTAINED BY MOD 1VMAN
**************************************************************************************************************************************************************************************************************************************************************
https://drive.google.com/file/d/17LRI6wJfjlaULH1fDKY7ZIDSAT0eqg_9/view?usp=sharing |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |